As of January 2025, Janssen Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has approved a chewable formulation of Vermox (mebendazole). This development marks a significant milestone in global health initiatives aimed at addressing the prevalence of Continue reading